Procter & Gamble Health Limited, today, touched a milestone of achieving their 52-week high figure at Rs 5,147.90, which is the day’s high number as well. The company marked its all-time high figure at Rs 7,499.95 in February 2021 and comparing that price with the current levels, there is a fall of around 33.3 percent.
The stock opened its trading session at the 52-week high figure itself and is currently trading at Rs 5,081 showing a downfall of around 1.32 percent. Having a bird’s eye view of how the stock performed over a longer horizon, the stock was able to deliver healthy upside movement of around 18 percent within a span of 6 months.
Procter & Gamble Health Limited is one of India’s largest companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life.
It was set up in India as one of Merck’s Asian subsidiaries in 1967. On December 1st, 2018, P&G successfully completed the acquisition of Merck’s Consumer Health business further to approval of all relevant regulatory authorities and the fulfillment of other customary closing conditions.
Being the first Merck Group Company, the company combines the best of P&G and Legacy Merck’s Consumer Health capabilities and cultures. It has a strong portfolio of brands backed by science and trusted by doctors, pharmacists, and consumers.
Having a look upon the financials of the company after a successful rally the stock has seen, the revenues are on an upward scale and show a growth of around 4 percent, on a QoQ basis, from Rs 297 crores in Q2 to Rs 309 crores in Q3.
Another factor to focus upon, being the net profits, witnessed a growth of a healthy 21 percent which is a shift from Rs 63 crores in Q2 to Rs 76 crores in Q3.
Apart from the profitability ratios, the margins of the company, specifically the net profit and operating profit margins, have proven to be 24.7% and 35.6% respectively on a QoQ basis.
The FIIs have shown faith in the company and thus, reflecting that aspect, they increased their shareholdings from 6.05% in Q2 to 6.33% in Q3. During the period, the promoter’s holding remained unchanged at 51.82 percent
with zero shares pledged. The small-cap stock has a market capitalization of Rs 8,436 Crore and a dividend yield of 1.03 percent.
Written by Amit Madnani